Noncoding RNA, friend or foe for nephrolithiasis?

Nephrolithiasis is one of the most common diseases in urology, characterized by notable incidence and recurrence rates, leading to significant morbidity and financial burden. Despite its prevalence, the precise mechanisms underlying stone formation remain incompletely understood, thus hindering sign...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing Wang, Zhenlu Yang, Xiaolong Chen, Yuanyuan Yang, Kehua Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2024.1457319/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846162521365413888
author Qing Wang
Zhenlu Yang
Xiaolong Chen
Yuanyuan Yang
Kehua Jiang
author_facet Qing Wang
Zhenlu Yang
Xiaolong Chen
Yuanyuan Yang
Kehua Jiang
author_sort Qing Wang
collection DOAJ
description Nephrolithiasis is one of the most common diseases in urology, characterized by notable incidence and recurrence rates, leading to significant morbidity and financial burden. Despite its prevalence, the precise mechanisms underlying stone formation remain incompletely understood, thus hindering significant advancements in kidney stone management over the past three decades. Investigating the pivotal biological molecules that govern stone formation has consistently been a challenging and high-priority task. A significant portion of mammalian genomes are transcribed into noncoding RNAs (ncRNAs), which have the ability to modulate gene expression and disease progression. They are thus emerging as a novel target class for diagnostics and pharmaceutical exploration. In recent years, the role of ncRNAs in stone formation has attracted burgeoning attention. They have been found to influence stone formation by regulating ion transportation, oxidative stress injury, inflammation, osteoblastic transformation, autophagy, and pyroptosis. These findings contributes new perspectives on the pathogenesis of nephrolithiasis. To enhance our understanding of the diagnostic and therapeutic potential of nephrolithiasis-associated ncRNAs, we summarized the expression profiles, biological functions, and clinical significance of these ncRNAs in the current review.
format Article
id doaj-art-015f1915b1d6432a86214922a8aa30f2
institution Kabale University
issn 2296-634X
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-015f1915b1d6432a86214922a8aa30f22024-11-20T06:26:45ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2024-11-011210.3389/fcell.2024.14573191457319Noncoding RNA, friend or foe for nephrolithiasis?Qing Wang0Zhenlu Yang1Xiaolong Chen2Yuanyuan Yang3Kehua Jiang4Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaDepartment of Radiology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaDepartment of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Urology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaNephrolithiasis is one of the most common diseases in urology, characterized by notable incidence and recurrence rates, leading to significant morbidity and financial burden. Despite its prevalence, the precise mechanisms underlying stone formation remain incompletely understood, thus hindering significant advancements in kidney stone management over the past three decades. Investigating the pivotal biological molecules that govern stone formation has consistently been a challenging and high-priority task. A significant portion of mammalian genomes are transcribed into noncoding RNAs (ncRNAs), which have the ability to modulate gene expression and disease progression. They are thus emerging as a novel target class for diagnostics and pharmaceutical exploration. In recent years, the role of ncRNAs in stone formation has attracted burgeoning attention. They have been found to influence stone formation by regulating ion transportation, oxidative stress injury, inflammation, osteoblastic transformation, autophagy, and pyroptosis. These findings contributes new perspectives on the pathogenesis of nephrolithiasis. To enhance our understanding of the diagnostic and therapeutic potential of nephrolithiasis-associated ncRNAs, we summarized the expression profiles, biological functions, and clinical significance of these ncRNAs in the current review.https://www.frontiersin.org/articles/10.3389/fcell.2024.1457319/fullncRNAsnephrolithiasiscalcium oxalatebiomarkerstherapeutic targets
spellingShingle Qing Wang
Zhenlu Yang
Xiaolong Chen
Yuanyuan Yang
Kehua Jiang
Noncoding RNA, friend or foe for nephrolithiasis?
Frontiers in Cell and Developmental Biology
ncRNAs
nephrolithiasis
calcium oxalate
biomarkers
therapeutic targets
title Noncoding RNA, friend or foe for nephrolithiasis?
title_full Noncoding RNA, friend or foe for nephrolithiasis?
title_fullStr Noncoding RNA, friend or foe for nephrolithiasis?
title_full_unstemmed Noncoding RNA, friend or foe for nephrolithiasis?
title_short Noncoding RNA, friend or foe for nephrolithiasis?
title_sort noncoding rna friend or foe for nephrolithiasis
topic ncRNAs
nephrolithiasis
calcium oxalate
biomarkers
therapeutic targets
url https://www.frontiersin.org/articles/10.3389/fcell.2024.1457319/full
work_keys_str_mv AT qingwang noncodingrnafriendorfoefornephrolithiasis
AT zhenluyang noncodingrnafriendorfoefornephrolithiasis
AT xiaolongchen noncodingrnafriendorfoefornephrolithiasis
AT yuanyuanyang noncodingrnafriendorfoefornephrolithiasis
AT kehuajiang noncodingrnafriendorfoefornephrolithiasis